-

SMAIO: 2024 Financial Calendar

LYON, France--(BUSINESS WIRE)--Regulatory News:

SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA, PEA-PME eligible) (Paris:ALSMA), a French player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today announces its indicative financial calendar for 2024.

Events

Dates

2023 full-year revenue

Tuesday, January 23, 2024

2023 full-year results

Tuesday April 16, 2024

Annual general meeting

Tuesday, June 18, 2024

2024 first-half revenue

Tuesday, July 16, 2024

2024 first-half results

Tuesday, October 15, 2024

This preliminary agenda may be modified. Each publication will be released after market close.

About SMAIO

A precursor in the use of clinical data and imaging of the spine, SMAIO designs global solutions for spine surgery specialists. The Company has recognized expertise thanks to KEOPS, its Big Data management software that has become a global reference with more than 100,000 patient cases documented.

SMAIO offers spine surgeons a comprehensive platform, I-Kontrol, incorporating planning, implants and related services, enabling them to treat spinal pathologies in a safe, effective and lasting way.

SMAIO is positioned at the forefront of innovation with the ambition of providing surgeons with the first active robotic solution enabling a high level of performance and repeatability to be achieved.

Based in Lyon, France, SMAIO benefits from the skill and expertise of more than 30 highly specialized staff.

For further information, please visit our website: www.smaio.com

Listing market: Euronext Growth Paris
ISIN: FR0014005I80
Ticker: ALSMA

Contacts

SMAIO
Philippe Roussouly
Chief Executive Officer
Renaut Fritsch
Chief Financial Officer
investors@smaio.com

NewCap
Dusan Oresansky/Quentin Massé
Investor Relations
smaio@newcap.eu
Tel.: +33 (0)1 44 71 94 92

NewCap
Arthur Rouillé
Media Relations
smaio@newcap.eu
Tel.: +33 (0)1 44 71 00 15

SMAIO

BOURSE:ALSMA

Release Versions

Contacts

SMAIO
Philippe Roussouly
Chief Executive Officer
Renaut Fritsch
Chief Financial Officer
investors@smaio.com

NewCap
Dusan Oresansky/Quentin Massé
Investor Relations
smaio@newcap.eu
Tel.: +33 (0)1 44 71 94 92

NewCap
Arthur Rouillé
Media Relations
smaio@newcap.eu
Tel.: +33 (0)1 44 71 00 15

More News From SMAIO

SMAIO Reports Sales for the First Half of 2026

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN Code: FR0014005I80 / Ticker: ALSMA, eligible for the PEA-PME scheme), a French-American player specialized in complex spine surgery, offering an integrated pre, intra, and post-operative solution based on a 3D planning software, adaptive implants, and related services, today announced its sales and cash position as of June 30, 2026. Philippe ROUS...

SMAIO Reported Revenue of €2.8 Million in the First Quarter of 2026, an Increase of 11%

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN Code: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, adaptive implants and related services, today announced its revenue for the first quarter of 2026. Philippe ROUSSOULY, Chairman and CEO of SMAIO, stat...

SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, announces the appointment of Dr. Jeffrey M. Hills, an orthopedic surgeon specializing in complex spinal surgery and Assistant Professor (Clinical) at UT...
Back to Newsroom